{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Earth City",
      "state": "MO",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "82326",
      "recalling_firm": "Legacy Pharmaceutical Packaging LLC",
      "address_1": "13333 Lakefront Dr",
      "address_2": "N/A",
      "postal_code": "63045-1514",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Wal-Mart distribution centers in AR, CA, GA, IN and MD",
      "recall_number": "D-1049-2019",
      "product_description": "Losartan Potassium Tablets, USP, 50 mg, 30 tablet bottles, Rx Only, Distributed by: Wal-Mart, Bentonville, AR 72716, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, Packaged by:  Legacy Pharmaceutical Packaging LLC, Earth City, MO 63045.  NDC 68645-578-54",
      "product_quantity": "2,851,284 bottles",
      "reason_for_recall": "CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) detected",
      "recall_initiation_date": "20190301",
      "center_classification_date": "20190321",
      "report_date": "20190327",
      "code_info": "Lots: 180921, exp Sep-19,  180922, exp Oct-19, 180923, 180924, 181118, exp Nov-19, 181119, exp Oct-19, 181407, exp Nov-19,  181408, exp Dec-19, 181573, 181725, 181726, exp Feb-20, 181948, exp Mar-20, 181960, exp Feb-20, 182385, 182386, 182387, exp Mar-20"
    }
  ]
}